跳至主要内容
临床试验/NCT05317455
NCT05317455招募中1 期

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

Yale University2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2025年5月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
16
试验地点
2
主要终点
Cognitive Function

研究概览

简要总结

This is a prospective randomized placebo-controlled double-blind crossover pilot study determining the effect of dichloroacetate on brain function under clamped hypoglycemia in T1DM.

详细描述

This study is a prospective randomized placebo-controlled double-blind crossover study designed to address the hypothesis that dichloroacetate has the ability to re-activate brain glucose metabolism under clamped hypoglycemia. The study population is comprised of intensively treated persons with T1D with frequent exposure to hypoglycemia, who have cognitive deficits under hypoglycemia that could be attributed to changes in brain glucose oxidation. The investigators will test the experimental compound DCA in a study that determines whether restoring brain glucose metabolism under hypoglycemia helps maintain cognitive function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • T1DM subjects with:
  • a history of severe hypoglycemia and/or hypoglycemia unawareness or
  • a history of severe hypoglycemia with a blood glucose <54 mg/dL, requiring the assistance of another person (with recovery after the administration of oral carbohydrate, intravenous glucose, or glucagon) or
  • at least 2 values <54mg/dl during 2 weeks of CGMS testing during the week prior to study.

排除标准

  • Age < 18 years or >55 years.
  • Body weight >85 kg at screening visit
  • BMI > 30 (female) and >30 (male) kg/m
  • Untreated proliferative retinopathy
  • carriers of glutathione transferase Z1 (GSTZ-1) gene polymorphisms that predispose to DCA accumulation and toxicity

研究组 & 干预措施

Placebo

Placebo Comparator

oral solution with flavoring agent, no active drug.

干预措施: Dichloroacetate (Drug)

Dichloroacetate

Active Comparator

oral solution of dichloroacetate with flavoring agent

干预措施: Dichloroacetate (Drug)

结局指标

主要结局

Cognitive Function

时间窗: 1 day

Measures of reaction time \[in milliseconds\] and cognitive testing performance under hypoglycemia \[percentage\].

次要结局

  • Brain glucose metabolism(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Raimund Herzog

Associate Professor of Medicine

Yale University

研究点 (2)

Loading locations...

相似试验